Huan‐You Wang

4.0k total citations
138 papers, 2.9k citations indexed

About

Huan‐You Wang is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Huan‐You Wang has authored 138 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pathology and Forensic Medicine, 40 papers in Oncology and 33 papers in Genetics. Recurrent topics in Huan‐You Wang's work include Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Viral-associated cancers and disorders (24 papers). Huan‐You Wang is often cited by papers focused on Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Viral-associated cancers and disorders (24 papers). Huan‐You Wang collaborates with scholars based in United States, China and United Kingdom. Huan‐You Wang's co-authors include Xiang‐Dong Fu, Joanne M. Yeakley, Jacqueline A. Dyck, Xiangdong Xu, John R. Bermingham, Zhou Songyang, Lewis C. Cantley, Stacey E. Mills, Hui Xu and Nitin J. Karandikar and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Huan‐You Wang

129 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huan‐You Wang United States 24 1.2k 761 567 442 378 138 2.9k
Martina Rudelius Germany 31 1.1k 0.9× 902 1.2× 463 0.8× 590 1.3× 512 1.4× 89 3.0k
Thomas Moritz Germany 27 1.1k 0.9× 423 0.6× 234 0.4× 649 1.5× 217 0.6× 90 2.8k
Martin Falk Czechia 33 2.1k 1.7× 921 1.2× 269 0.5× 525 1.2× 160 0.4× 119 3.8k
Matthias Holdhoff United States 27 596 0.5× 604 0.8× 317 0.6× 248 0.6× 821 2.2× 111 2.1k
Ralf Huss Germany 35 1.1k 0.9× 971 1.3× 163 0.3× 696 1.6× 1.4k 3.8× 111 3.9k
Martina Rudelius Germany 24 595 0.5× 594 0.8× 156 0.3× 236 0.5× 112 0.3× 43 1.8k
Judith Runnels United States 25 1.5k 1.3× 674 0.9× 335 0.6× 675 1.5× 719 1.9× 64 3.5k
Andreas Gäumann Germany 29 1.4k 1.2× 753 1.0× 204 0.4× 247 0.6× 186 0.5× 101 3.3k
Hiroya Hashizume Japan 15 2.4k 2.0× 1.6k 2.1× 173 0.3× 362 0.8× 194 0.5× 24 4.7k
Wayne L. Monsky United States 27 1.7k 1.4× 895 1.2× 110 0.2× 349 0.8× 161 0.4× 84 5.2k

Countries citing papers authored by Huan‐You Wang

Since Specialization
Citations

This map shows the geographic impact of Huan‐You Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan‐You Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan‐You Wang more than expected).

Fields of papers citing papers by Huan‐You Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan‐You Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan‐You Wang. The network helps show where Huan‐You Wang may publish in the future.

Co-authorship network of co-authors of Huan‐You Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Huan‐You Wang. A scholar is included among the top collaborators of Huan‐You Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan‐You Wang. Huan‐You Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Lindsay, Shreya Mishra, Alexandra Bortnick, et al.. (2024). Nuclear morphology is shaped by loop-extrusion programs. Nature. 627(8002). 196–203. 14 indexed citations
3.
Li, Peng, Margaret S. Williams, Thomas A. White, et al.. (2022). The genetic landscape of germlineDDX41variants predisposing to myeloid neoplasms. Blood. 140(7). 716–755. 43 indexed citations
4.
He, Cuiying, Huan‐You Wang, Guimin Zhao, et al.. (2022). Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells. BMC Cancer. 22(1). 1100–1100. 4 indexed citations
5.
Li, Peng, Thomas A. White, Wei Xie, et al.. (2021). AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome. Leukemia. 36(3). 664–674. 36 indexed citations
6.
Tao, Han, Zengqi Xie, Lei Ying, et al.. (2020). Energy level gradient trapping based on different work functions of ZnO enhancing response and stablity for lateral photodetectors. Organic Electronics. 86. 105883–105883. 11 indexed citations
7.
Evans, Mark G., Roberto N. Miranda, Patricia A. Young, et al.. (2020). B-cell lymphomas associated with breast implants: Report of three cases and review of the literature. Annals of Diagnostic Pathology. 46. 151512–151512. 17 indexed citations
8.
Tao, Han, Linlin Liu, Zengqi Xie, et al.. (2019). Ultrahigh photosensitive organic phototransistors by photoelectric dual control. Journal of Materials Chemistry C. 7(16). 4725–4732. 27 indexed citations
9.
Stoner, Samuel A., Ming Yan, Katherine Liu, et al.. (2019). Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation. Blood. 134(20). 1730–1744. 12 indexed citations
10.
Choi, Michael Y., Huan‐You Wang, & Thomas J. Kipps. (2019). SOHO State of the Art Updates and Next Questions: The Conundrum in Assessing the Therapy Response of Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 19(6). 321–325. 1 indexed citations
11.
Kang, Xunlei, Changhao Cui, Chen Wang, et al.. (2018). CAMKs support development of acute myeloid leukemia. Journal of Hematology & Oncology. 11(1). 30–30. 30 indexed citations
12.
Scheuermann, Richard H., Jack D. Bui, Huan‐You Wang, & Qian Yu. (2017). Automated Analysis of Clinical Flow Cytometry Data. Clinics in Laboratory Medicine. 37(4). 931–944. 5 indexed citations
15.
Broome, H. Elizabeth, et al.. (2011). ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia. Leukemia Research. 35(10). 1390–1394. 59 indexed citations
16.
Li, Ke, Ann Tipps, & Huan‐You Wang. (2010). Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting as an isolated nasopharyngeal mass: a case report and review of literature.. PubMed Central. 13 indexed citations
17.
Wang, Huan‐You, et al.. (2010). BCL2 Chromosomal Translocation Is Not a General Feature of the Interdigitating Dendritic Cell Sarcoma. Diagnostic Molecular Pathology. 19(3). 169–171. 3 indexed citations
18.
Wang, Huan‐You & Carlos A Tirado. (2009). t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymophoblastic leukemia. Human Pathology. 41(2). 286–292. 1 indexed citations
19.
Wang, Huan‐You. (2008). First principle study on dielectric and elastic properties of zinc-blended AlN, AlP and AlAs. The Chinese Journal of Nonferrous Metals. 1 indexed citations
20.
Wang, Huan‐You, et al.. (2001). SC35 Plays a Role in T Cell Development and Alternative Splicing of CD45. Molecular Cell. 7(2). 331–342. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026